A Standardized Diagnostic Interview for Hypoactive Sexual Desire Disorder in Women: Standard Operating Procedure (SOP Part 2)

Journal of Sexual Medicine

Volumn 10, Issue 1, 2013, Pages 50-57

  Bitzer, Johannes ^a   Giraldi, Annamaria ^b   Pfaus, Jim ^c  

^a UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

^b Psychiatric Center Copenhagen   (Denmark)

^c Concordia University ^*  (Canada)

Author keywords

Hypoactive Sexual Desire Disorder; Semistructured Interview and Examination; Standard Operating Procedure

Indexed keywords

BREMELANOTIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; ESTROGEN; FLIBANSERIN; TESTOSTERONE; TRIPLE REUPTAKE INHIBITOR;

ARTICLE; BIOMEDICINE; DISTRESS SYNDROME; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN RELATION; HYPOACTIVE SEXUAL DESIRE DISORDER; MEDICAL EXAMINATION; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; SEMI STRUCTURED INTERVIEW; SOCIAL ASPECT;

EID: 84872835975     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.02817.x     Document Type: Article

References (36)

1. Bitzer J, Alder J. Sexualstörungen bei der Frau. Ther Umsch 2010;67:105-16.
2. Bitzer J, Platano G, Tschudin S, Alder J. Sexual counseling for women in the context of physical diseases-A teaching model for physicians. J Sex Med 2007;4:29-37.
3. Clayton AH, Goldfischer ER, Goldstein I, Derogatis L, Lewis-D'Agostino DJ, Pyke R. Validation of the Decreased (HSDD). Sexual Desire Screener (DSDS): A brief diagnostic instrumenfor generalized acquired female Hypoactive Sexual Desire Disorder. J Sex Med 2009;6:730-8.
4. Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002;28:317-30.
5. Brandenburg U, Bitzer J. The challenge of talking about sex: The importance of patient-physician interaction. Maturitas 2009;63:124-7.
6. Bitzer J, Brandenburg U. Psychotherapeutic interactions for female sexual dysfunction. Maturitas 2009;63:160-3.
7. Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 2003;79:1341.
8. Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Bearnson P, Kakos N, O'Neill S, Levine S, Wekselman K, Buch A, Rodenberg C, Kroll R. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study. Menopause 2006;13:770.
9. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682.
10. Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, Rodenberg CA, Wekselman K, Casson P. Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol 2005;105:944.
11. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial. Arch Intern Med 2005;165:1582.
12. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226.
13. Laan E, van Lunsen RH, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001;4:28-41.
14. 2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: Results of a randomized active-controlled trial. J Sex Med 2008;5:646-56.
15. Labrie F, Luu-The V, Bélanger A, Lin S-X, Simard J, Labrie C. Is DHEA a hormone? Starling review. J Endocrinol 2005;187:169-96.
16. Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J. Effect on intravaginal Prasterone (DHEA) on libido and sexual dysfunction in postmenopausal women. Menopause 2009;16:923-31.
17. Balon R, Segraves RT. Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants. J Sex Marital Ther 2008;34:353-65.
18. Krapf JM, Simon JA. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Maturitas 2009;63:213-9.
19. Davis S, Papalia MA, Norman RJ, O'Neill S, Redelman M, Williamson M, Stuckey BG, Wlodarczyk J, Gard'ner K, Humberstone A. Safety and efficacy of testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: A randomized trial. Ann Intern Med 2008;148:569-77.
20. Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot C, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial. Menopause 2006;13:387-96.
21. Sherwin BB. Randomized clinical trials of combined estrogen-androgen preparations: Effects on sexual functioning. Fertil Steril 2002;77(suppl 4):S49-54.
22. Miller KK, Perlis RH, Papakostas GL, Mischoulon D, Losifescu DV, Brick DJ, Fava M. Low-dose transdermal testosterone augmentation therapy improves depression severity in women. CNS Spectr 2009;14:688-94.
23. van der Made F, Bloemers J, Yassem WE, Kleiverda G, Everaerd W, van Ham D, Olivier B, Koppeschaar H, Tuiten A. The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction. J Sex Med 2009;6:777-90.
24. Clayton AH. Extended-release bupropion: An antidepressant with a broad spectrum of therapeutic activity? Expert Opin Pharmacother 2007;8:457-66.
25. Pfaus J, Giuliano F, Gelez H. Bremelanotide: An overview of preclinical CNS effects on female sexual function. J Sex Med 2007;4(suppl 4):269-79.
26. Shadiack AM, Sharma SD, Earle DC, Spana C, Hallam TJ. Melanocortins in the treatment of male and female sexual dysfunction. Curr Top Med Chem 2007;7:1137-44.
27. Perelman MA. Clinical application of CNS-acting agents in FSD. J Sex Med 2007;4(suppl 4):280-90.
28. Ferger B, Shimasaki M, Ceci A, Ittrich C, Allers KA, Sommer B. Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats. Naunyn Schmiedebergs Arch Pharmacol 2010;381:573-9.
29. Stahl SM, Sommer B, Allers KA. Multifunctional pharmacology of flibanersin: Possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med 2011;8:15-27.
30. Trudel G, Marchand A, Ravart M, Aubin S, Turgeon L, Fortier P. The effect of a cognitive behavioral treatment program on hypoactive sexual desire in women. Sex Relat Ther 2003;16:145-64.
31. Hawton K, Catalan J, Fagg J. Low sexual desire: Sex therapy results and prognostic factors. Behav Res Ther 1991;29:217-24.
32. Pridal CG, LoPiccolo J. Multielement treatment of desire disorders. In: Leiblum SR, Rosen RC, eds. Principles and practice of sex therapy. 3rd edition. New York: Guilford; 2000:57-81.
33. Kaplan HS. Hypoactive sexual desire. J Sex Marital Ther 1977;3:3-9.
34. Kaplan HS. In: Kaplan HS, ed. Disorders of sexual desire. New York: Brunner/Mazel; 1979:30-4.
35. Sarwer DB, Durlak JA. A field trial of the effectiveness of behavioral treatment for sexual dysfunctions. J Sex Marital Ther 1997;23:87-97.
36. Brotto LA, Basson R, Luria M. A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women. J Sex Med 2008;5:1646-59.